Emulate Contract Research Services

Conventional approaches to drug discovery and development are time-consuming, costly, and have low success rates, as evidenced by a mere 10% of Phase 1 clinical programs culminating in an FDA-approved drug.

This situation is not just frustrating; it's also counterproductive, hampering the timely introduction of potentially life-changing therapies for millions of patients.

Fortunately, Organ-on-a-Chip technology offers a solution by overcoming the limitations of animal models and traditional in vitro studies. By accurately emulating human biology within a controlled microenvironment, complete with fluid flow, stretch, and cell-cell interactions, Organ-Chips provide a more accurate assessment of a drug candidate's impact on human physiology at a much earlier stage of the process.

Discover how you can harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.